Rock Springs Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,306,196
| Closed | -$41.5M | – | 162 |
|
|
2020
Q2 | $41.5M | Buy |
2,306,196
+554,296
| +32% | +$7.71M | 1.14% | 29 |
|
|
2020
Q1 | $12.5M | Buy |
1,751,900
+851,900
| +95% | +$10.6M | 0.52% | 64 |
|
|
2019
Q4 | $21.5M | Sell |
900,000
-150,000
| -14% | -$4.14M | 0.68% | 58 |
|
|
2019
Q3 | $28.2M | Buy |
1,050,000
+42,000
| +4% | +$1.18M | 1.12% | 27 |
|
|
2019
Q2 | $27.3M | Buy |
1,008,000
+133,000
| +15% | +$4.17M | 0.99% | 34 |
|
|
2019
Q1 | $30.4M | Buy |
875,000
+575,000
| +192% | +$16.6M | 1.17% | 23 |
|
|
2018
Q4 | $5.86M | Sell |
300,000
-23,800
| -7% | -$489K | 0.28% | 91 |
|
|
2018
Q3 | $8.62M | Hold |
323,800
| – | – | 0.31% | 92 |
|
|
2018
Q2 | $12.2M | Hold |
323,800
| – | – | 0.47% | 73 |
|
|
2018
Q1 | $10.6M | Hold |
323,800
| – | – | 0.45% | 76 |
|
|
2017
Q4 | $15.8M | Hold |
323,800
| – | – | 0.72% | 49 |
|
|
2017
Q3 | $17.5M | Buy |
323,800
+184,100
| +132% | +$10.8M | 0.81% | 46 |
|
|
2017
Q2 | $7.85M | Buy |
+139,700
| New | +$5.6M | 0.4% | 77 |
|
|
2016
Q3 | – | Sell |
-175,000
| Closed | -$4.13M | – | 145 |
|
|
2016
Q2 | $4.13M | Hold |
175,000
| – | – | 0.31% | 90 |
|
|
2016
Q1 | $3.57M | Buy |
175,000
+10,000
| +6% | +$317K | 0.3% | 94 |
|
|
2015
Q4 | $8.49M | Buy |
+165,000
| New | +$8M | 0.64% | 56 |
|
Rock Springs Capital Management's PTLA Position: Q3 2020 in Review
Rock Springs Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,306,196 shares — an estimated $41.5M sold.
Rock Springs Capital Management first reported a position in PTLA in Q4 2015 and held it in 16 quarters. The position peaked at $41.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Rock Springs Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Rock Springs Capital Management sold 2,306,196 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $41.5M.
- Rock Springs Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 16 quarters.
- Rock Springs Capital Management's Portola Pharmaceuticals, Inc. position peaked at $41.5M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Rock Springs Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.